NCT02722356View on ClinicalTrials.gov

Outcomes After the Implementation of a New Oxytocin Protocol

NACompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions
Complications; Cesarean SectionAdverse Reaction to Oxytocin
Interventions
DRUG

Oxytocin

Oxytocin administered per oxytocin group or standard practice group (see above)

All Listed Sponsors
lead

C.R.Darnall Army Medical Center

FED

NCT02722356 - Outcomes After the Implementation of a New Oxytocin Protocol | Biotech Hunter | Biotech Hunter